Skip to main content

Table 3 Independent prognostic analysis based on clinical characteristics and risk score

From: Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways

Variables

Univariate analysis

Multivariate analysis

HR(95% CI)

p value

HR(95% CI)

p value

Age

1.012(0.993–1.032)

0.213

  

Sex (Male vs Female)

0.916(0.636–1.321)

0.639

  

T_stage (T3/T4 vs T1/T2)

2.119(1.315–3.413)

0.002

1.273(0.745–2.175)

0.377

N_stage (N1–3 vs N0)

3.161(2.186–4.569)

9.30644E-10

2.248(1.445–3.493)

0.0003

M_stage (M1 vs M0)

2.028(1.051–3.911)

0.035

1.436(0.690–2.990)

0.333

M_stage (Unk vs M0)

0.586(0.359–0.953)

0.031

0.699(0.427–1.145)

0.155

TNM_Stage (III/IV vs I/II)

3.054(2.099–4.445)

5.49327E-09

1.456(0.862–2.461)

0.160

riskScore

3.752(2.087–6.748)

1.00289E-05

2.336(1.285–4.246)

0.0005